Jesper Funding Andersen, CEO – ORIGIO a/s
Master of Business Economics from Copenhagen Business School. Born 1966. Appointed CEO of ORIGIO a/s in November 2005. Previous experience includes Management Consultant in McKinsey & Co. Inc. (a global strategy consulting company), Group Vice President at Maersk Medical A/S (a leading Danish medical device company), and Senior Vice President for International Business at GN Resound A/S (a large Danish hearing aid company). Member of the Board of Directors of MissionPharma A/S (a supplier of generic pharmaceutical to third world countries), Ambu (a leading listed Danish med-tech company), and Chairman in Ellipse A/S (a Danish supplier of laser and light based medical equipment). Owns 144,072 shares and 840,000 warrants.

 Søren Østergaard, EVP International Sales – ORIGIO a/s
Bachelor of Science in Medical engineering from Engineering Academy of Aarhus, Denmark. Born 1959. Appointed Executive Vice President International Sales December 2007. Previous experience includes more than 20 years of international sales & marketing experience in the medical technology sector, latest as Vice President and General Manager in GN Resound (hearing aid) and as Director of Sales in Europe at Medicotest (a Danish manufacturer of electrodes for medical applications). Owns 3,458 shares and 125,000 warrants.

 Susanne Hauschildt Bendz, CSO, EVP Innovation and Corporate Marketing – ORIGIO a/s
Ph.D. in biology (immunology) from University of Copenhagen. Born 1958. Appointed Executive Vice President, Innovation and Corporate Marketing August 2004. Previous experience includes Research Assistant, and Clinical Research Director at ALK-Abelló A/S (a leading allergy vaccine company) and later in Coloplast A/S in Wound Care Management Group and Corporate responsible for clinical development (the largest Danish Medical device company). Owns 39,575 shares and 205,000 warrants.

 Allan Toft Jacobsen, CPO, EVP Manufacturing – ORIGIO a/s
MSc in Chemical Engineering from Technical Univeristy of Denmark, specialized in microbiology and molecular biology. Born 1971. Joined ORIGIO in 2005. Appointed Executive Vice President Manufacturing December 2007. Previous 3 years manager for manufacturing and QC in ORIGIO a/s. Former experience includes various QC, manufacturing and production roles at Colgate Palmolive in Denmark and France. Owns 13,458 shares and 155,000 warrants.

 Jeannett Hvidkjær, CFO – ORIGIO a/s
Bachelor in Business Economics and Accounting from Copenhagen Business School. Born 1966. Joined ORIGIO in 2005 as Chief Accountant. Appointed Chief Financial Officer August 2009. 12 years experience as a public accountant at Ernst&Young and 5 years as Chief Account at a national Danish newspaper. Owns 3,458 shares and 115,000 warrants.

 Debra Bryant, EVP ORIGIO a/s, CEO – ORIGIO Inc.
Ph.D. Microbiology, Wake Forest University, 1980. Born 1955. NIH Postdoctoral Fellow in Molecular Biology, 1980-1983. Research Scientist, Oncogen (owned by Bristol Myers) 1983-1984. Research Scientist for Humagen 1984-1990. Purchased Humagen 1990. CEO of Humagen, 1990. 2007, appointed Executive Vice President ORIGIO a/s and CEO, ORIGIO Humagen Pipets Inc. Owns 312,548 shares, 70,000 warrants.